ChrysCapital realises Fund IV with Mankind exit

Healthcare investor ChrysCapital sold its stake in Delhi-based pharmaceuticals company Mankind Pharma to investment firm Capital International for $190 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this